Bristol Myers Squibb (CELG-RI) Shares Outstanding (Weighted Average) (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $2.0 billion in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $2.0 billion, changed 0.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 billion (changed 0.34% YoY), and the FY2025 annual result was $2.0 billion, changed 0.35% from the prior year.
• Shares Outstanding (Weighted Average) steadied at $2.0 billion in Q1 2026 per CELG-RI's latest filing, from $2.0 billion in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $2.1 billion in Q1 2022 and troughed at $2.0 billion in Q1 2024.
• A 5-year average of $2.1 billion and a median of $2.0 billion in 2026 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) slipped 4.44% in 2022, then gained 0.4% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.1 billion in 2022, then fell by 2.86% to $2.1 billion in 2023, then fell by 2.03% to $2.0 billion in 2024, then gained by 0.35% to $2.0 billion in 2025, then grew by 0.2% to $2.0 billion in 2026.
• Business Quant data shows CELG-RI's Shares Outstanding (Weighted Average) at $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and $2.0 billion in Q3 2025.